Elise Roy
About Elise Roy
Elise Roy is a Manager and Study Scientist at Bristol Myers Squibb with extensive experience in clinical trials, regulatory processes, and cell and gene therapy.
Current Role at Bristol Myers Squibb
Elise Roy currently holds the position of Manager, Study Scientist at Bristol Myers Squibb. In this role, she is responsible for managing post-approval studies for CAR T Cell Therapy products, specifically Abecma and Breyanzi. Her expertise in hematology-oncology, particularly in the area of cell and gene therapy, is instrumental in her contributions to the company's ongoing projects.
Professional Experience at Debiopharm
From 2018 to 2020, Elise Roy served as a Clinical Trial Manager at Debiopharm. During her tenure, she managed various clinical trials, ensuring compliance with regulatory standards and contributing to the development of new therapeutic treatments. Her role involved overseeing clinical trial operations and coordinating with cross-functional teams to meet project milestones.
Role at ENYO Pharma
Elise Roy worked as a Clinical Project Manager at ENYO Pharma from 2017 to 2018. She was responsible for managing clinical projects, which included planning, implementation, and tracking of progress. This role allowed her to enhance her project management skills and deepen her understanding of clinical development processes.
Educational Background
Elise Roy completed her Doctor of Philosophy (PhD) in Molecular and Cell Biology at Université Paris Cité from 2008 to 2011. Before this, she achieved an Engineer diploma (Master of Science) in Biotechnology from the ESBS – European Superior School of Biotechnology of Strasbourg, France, from 2003 to 2006. Additionally, she undertook training courses on Clinical Trials and GMP Manufacturing between 2012 and 2015.
Gene Therapy Research at Institut Pasteur
During her PhD fellowship from 2008 to 2012, Elise Roy contributed to gene therapy research at Institut Pasteur within the Gene Therapy Unit. Her research focused on advancing the field of gene therapy, providing her with a solid foundation in experimental techniques and theoretical knowledge related to this specialized field.